Systemic corticosteroid toxicity from topical and periocular

[Mike Bartolatz]

You have requested access to the following article:

Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis .
American Journal of Ophthalmology , Volume 130 , Issue 2 , Pages 240 - 241
U . Ozerdem

To view this article, please choose one of your preferred Elsevier websites:


Access to the full-text of this article will depend on your personal or institutional entitlements.
Preferred Websites
Article via ScienceDirect

Article via Elsevier Health Sciences - Elsevier imprints, theclinics.com, and ophsource.org

Article via Elsevier's Beta Program - Patient Research


To skip this screen in the future, update your preferred Elsevier websites . To learn more, read help
Update My Preferred Elsevier Websites



Abstract
PURPOSE: To report a case of systemic corticosteroid toxicity resulting from topical and periocular therapy.

METHODS: Treatment and follow-up of an 11-year-old male with uveitis are illustrated. Initial presentation of the patient was bilateral iridocyclitis, for which he was treated with prednisolone acetate 1% every 2 hours for 6 months. Subsequently, posterior uveitis developed, necessitating posterior subtenon injections.

RESULTS: After initial topical corticosteroid therapy, the patient developed a cushingoid habitus accompanied by increased lanugo hair, acanthosis nigricans, posterior subcapsular lens opacities, and increased intraocular pressure. Cushingoid stigmata worsened after administration of posterior subtenon injection of corticosteroids. The patient’s truncal obesity worsened, and his linear growth stopped.

CONCLUSIONS: Systemic toxic effects may develop as a result of topical and local use of ophthalmic corticosteroid preparations in susceptible patients.

Copyright © 2003 Elsevier Inc. All rights reserved. Feedback | About Article Finder | Help